煙臺東(dong)誠藥(yao)(yao)業集(ji)團股份有(you)限公(gong)司(前身為煙臺東(dong)誠生(sheng)(sheng)化(hua)股份有(you)限公(gong)司)成立于(yu)(yu)1998年,2012年5月在深交所上市(股票代碼002675)。歷經20余年的發(fa)展,東(dong)誠藥(yao)(yao)業現已成為一家(jia)覆蓋生(sheng)(sheng)化(hua)原料(liao)藥(yao)(yao)、化(hua)藥(yao)(yao)、中(zhong)成藥(yao)(yao)、核藥(yao)(yao)四(si)大領域,融藥(yao)(yao)品研發(fa)、生(sheng)(sheng)產、銷(xiao)售于(yu)(yu)一體的大型制藥(yao)(yao)企業集(ji)團。
集團控股煙臺(tai)東(dong)誠(cheng)北(bei)方制(zhi)藥(yao)有(you)(you)(you)限公(gong)(gong)(gong)司(si)、煙臺(tai)東(dong)誠(cheng)大(da)洋制(zhi)藥(yao)有(you)(you)(you)限公(gong)(gong)(gong)司(si)、臨沂東(dong)誠(cheng)東(dong)源生物工(gong)程(cheng)有(you)(you)(you)限公(gong)(gong)(gong)司(si)、中泰生物制(zhi)品有(you)(you)(you)限公(gong)(gong)(gong)司(si)、東(dong)誠(cheng)國際(ji)(香港)有(you)(you)(you)限公(gong)(gong)(gong)司(si)、成都云克藥(yao)業有(you)(you)(you)限責任公(gong)(gong)(gong)司(si)、上(shang)海欣科醫藥(yao)有(you)(you)(you)限公(gong)(gong)(gong)司(si)、上(shang)海益泰醫藥(yao)科技有(you)(you)(you)限公(gong)(gong)(gong)司(si)、南京江原安迪科正電(dian)子研究發(fa)展有(you)(you)(you)限公(gong)(gong)(gong)司(si)等40多(duo)家分(fen)子公(gong)(gong)(gong)司(si),集團在北(bei)京、上(shang)海、南京設立研發(fa)分(fen)支機構和辦(ban)事(shi)處,擁有(you)(you)(you)員(yuan)工(gong)近兩千人。
東誠(cheng)藥(yao)(yao)業作為國(guo)內前沿的生化(hua)原料藥(yao)(yao)生產(chan)(chan)企業,核心產(chan)(chan)品肝(gan)素鈉及硫酸軟骨素憑借(jie)優質質量,贏(ying)得了(le)眾(zhong)多(duo)的國(guo)際(ji)機(ji)構認證,產(chan)(chan)品90%以上(shang)銷往歐洲(zhou)、美洲(zhou)、亞太等全球40多(duo)個國(guo)家和地(di)區,與眾(zhong)多(duo)國(guo)際(ji)知名藥(yao)(yao)企建立了(le)穩(wen)定(ding)的合作關系。
東誠藥(yao)業(ye)不斷(duan)強化制劑(ji)業(ye)務,制劑(ji)產品(pin)覆(fu)蓋(gai)心血管(guan)、抗(kang)腫(zhong)瘤、泌尿、骨(gu)科等治療領域。近年來(lai),公司(si)高(gao)起點進(jin)入高(gao)技術壁壘和高(gao)成長性的核醫(yi)藥(yao)行業(ye),相繼并(bing)購(gou)國內多(duo)家核藥(yao)企業(ye),完成從診(zhen)斷(duan)用核藥(yao)到治療用核藥(yao)的全產業(ye)鏈布局(ju),奠(dian)定了公司(si)在中國核醫(yi)藥(yao)領域的前(qian)沿(yan)地位。
東誠藥業不(bu)斷加大科研投入,致力自主創新,引進(jin)泰山學者(zhe)、973科學家等高素質人才(cai)。通(tong)過建立(li)廣(guang)泛的產(chan)學研合(he)作網絡,實現新技術的引進(jin)轉化,通(tong)過創新驅(qu)動帶領企業發展。
在“立足東方,誠諾健康(kang)”企(qi)業使命指引下,東誠藥業將(jiang)深(shen)化資(zi)源整合、優(you)化產業結構、不斷提升企(qi)業創新能力與核心競爭力,以“全球肝素專(zhuan)家,中國核藥領軍(jun)企(qi)業”為目標,向著(zhu)成長(chang)為專(zhuan)業領域前沿(yan)的、持續創造優(you)異價值的制藥企(qi)業不斷邁進。